International Stem Cell (ISCO) EBT (QoQ) (2010 - 2025)
Powered by 
Analysis
International Stem Cell (ISCO) EBT (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | International Stem Cell | 3.36 Mn | 2.27 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -710.53% |
| Sep 30, 2025 | -55.81% |
| Jun 30, 2025 | 150.39% |
| Mar 31, 2025 | -2,233.33% |
| Dec 31, 2024 | 109.60% |
| Sep 30, 2024 | -209.65% |
| Jun 30, 2024 | 153.27% |
| Mar 31, 2024 | 53.28% |
| Dec 31, 2023 | -249.62% |
| Sep 30, 2023 | 26.82% |
| Jun 30, 2023 | -426.47% |
| Mar 31, 2023 | -221.43% |
| Dec 31, 2022 | 108.36% |
| Sep 30, 2022 | -16,650.00% |
| Jun 30, 2022 | 77.78% |
| Mar 31, 2022 | 97.53% |
| Dec 31, 2021 | 43.21% |
| Sep 30, 2021 | -44.04% |
| Jun 30, 2021 | 25.71% |
| Mar 31, 2021 | 21.29% |